Zayde Radwan, MD
Adult Reconstructive Orthopaedic Surgery · Pearland, TXNPI 1154686038
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $7,879 of the $12,270 with a category attached, or 64.2%. Stryker accounts for 92.1% of it on its own, with 6 other manufacturers making up the rest. That places this record below the midpoint for adult reconstructive orthopaedic surgery clinicians in TX, where the typical reported total is $14,244.
Across 79 payments — averaging $155.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$11K
- Encore Medical, LP$548
- Exactech, Inc.$140
- Biocomposites Inc$111
- Amgen$105
- Vertex$36
- plus $24 from 1 others
What the payments were for
- Travel & lodging$7,87964%
- Food & beverage$4,39236%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 63 | $11,307 |
| Encore Medical, LP | 6 | $548 |
| Exactech, Inc. | 1 | $140 |
| Biocomposites Inc | 1 | $111 |
| Amgen | 6 | $105 |
| Vertex | 1 | $36 |
| Intellijoint Surgical Inc. | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,270 in reported general payments places this provider in the 40th percentile of 86 adult reconstructive orthopaedic surgery providers in Texas.
See all adult reconstructive orthopaedic surgery providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 273 | $11,412 |
| Celecoxib | 238 | $6,771 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 200 | $3,142 |
| Meloxicam | 418 | $1,243 |
| Tizanidine Hcl | 153 | $891 |
| Tramadol Hcl | 163 | $732 |
| Pregabalin | 46 | $526 |
| Diclofenac Sodium ErDiclofenac Sodium | 15 | $467 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 102 | $406 |
| Doxycycline Monohydrate | 22 | $226 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 22 | $193 |
| Methylprednisolone | 27 | $177 |
| Ondansetron Hcl | 14 | $98 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Pearland
- Eddie HuangPearland$8K
- Tyler GoldbergAustin$4.6M
- Antonia ChenDallas$3.8M
- John BarringtonPlano$2.2M
- Roger EmersonPlano$691K
- Donald HohmanDallas$537K
- Steven WeedenFort Worth$370K
- Marcus FordFort Worth$296K
- Raul MarquezEdinburg$278K
- Richard ReitmanPlano$227K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.